Source-grounded facts extracted from Dolby Laboratories, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Dolby Laboratories, Inc. reported the second quarter of fiscal 2026 results: revenue $396 million, net income $95 million or $0.99 per diluted share, EPS $0.99 per diluted share.
“Total revenue was $396 million, compared to $370 million for the second quarter of fiscal 2025. • GAAP net income was $95 million or $0.99 per diluted share, compared to GAAP net income of $92 million or $0.94 per diluted share for the second quarter of fiscal 2025.”
Dolby Laboratories, Inc.: Approved amendment to provide for exculpation of certain officers from liability (effective 2025-02-05).
“At the Dolby Laboratories, Inc. (the “Company”) 2025 Annual Meeting of Stockholders (the “Annual Meeting”), held on February 4, 2025 via live webcast, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for the exculpation of certain of the Company’s officers from liability in specific circumstances, as permitted by Delaware law (the “Charter Amendment”).”
Dolby Laboratories, Inc. reported third quarter of fiscal 2024 and full year of fiscal 2024 results: EPS $0.21 to $0.36 on a GAAP basis and from $0.51 to $0.66 on a non-GAAP basis for Q3; $2.30 to $2.45 on a GAAP basis and fr. Guidance reaffirmed.
“Total revenue is estimated to range from $270 million to $300 million.”
Dolby Laboratories, Inc. reported second quarter of fiscal 2024 results: revenue $364.5 million, net income $97.8 million, EPS $1.01 per diluted share. Guidance reaffirmed.
“sports, music and more, driving more consumer device adoption and bringing Dolby to more people worldwide.” Second Quarter Fiscal 2024 Financial Highlights • Total revenue was $364.5 million, compared to $375.9 million for the second quarter of fiscal 2023. • GAAP net income was $97.8 million, or $1.01 per diluted share, compared to GAAP net income of $95.7 million,”
Dolby Laboratories, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending September 27, 2024 at the 2024-02-06 meeting.
“Proposal 5 - Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 27, 2024: Votes For Votes Against Abstentions 414,100,897 1,642,804 42,802”
Dolby Laboratories, Inc. shareholders approved Approval of an amendment to the Bylaws to add a forum selection provision at the 2024-02-06 meeting.
“Proposal 4 - Approval of an amendment to the Bylaws to add a forum selection provision: Votes For Votes Against Abstentions Broker Non-Votes 404,878,231 7,022,017 74,851 3,811,404”
Dolby Laboratories, Inc. shareholders approved Approval of an amendment to the advance notice procedures and other conforming changes to the Company's Amended and Restated Bylaws at the 2024-02-06 meeting.
“Proposal 3 - Approval of an amendment to the advance notice procedures and other conforming changes in the Bylaws: Votes For Votes Against Abstentions Broker Non-Votes 411,771,892 147,401 55,806 3,811,404”
Dolby Laboratories, Inc. shareholders approved Advisory vote to approve the compensation of the Company's named executive officers at the 2024-02-06 meeting.
“Proposal 2 - Approval of an advisory vote to approve the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 407,009,320 4,918,051 47,728 3,811,404”
Dolby Laboratories, Inc. shareholders approved Election of eight directors to serve until the 2025 Annual Meeting or until their successors are duly elected and qualified at the 2024-02-06 meeting.
“Proposal 1 - Election of directors: Director Votes For Votes Withheld Broker Non-Votes Kevin Yeaman 410,877,914 1,097,185 3,811,404 Peter Gotcher 388,282,890 23,692,209 3,811,404 David Dolby 394,701,829 17,273,270 3,811,404 Tony Prophet 394,220,509 17,754,590 3,811,404 Emily Rollins 411,451,087 524,012 3,811,404 Simon Segars 395,391,046 16,584,053 3,811,404 Anjali Sud 410,107,327 1,867,772 3,811,404 Avadis Tevanian, Jr. 393,293,685 18,681,414 3,811,404”
Dolby Laboratories, Inc. reported first quarter of fiscal 2024 results: revenue 315.6 million, net income 67.0 million, EPS 0.69.
“Total revenue was $315.6 million, compared to $334.9 million for the first quarter of fiscal 2023. • GAAP net income was $67.0 million, or $0.69 per diluted share, compared to GAAP net income of $79.4 million, or $0.82 per diluted share, for the first quarter of fiscal 2023.”
Dolby Laboratories, Inc. reported financial results for its fiscal quarter and fiscal year ended September 29, 2023.
“On November 16, 2023, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter and fiscal year ended September 29, 2023.”
Dolby Laboratories, Inc. reported third quarter of fiscal 2023 results: revenue $298.4 million, net income $16.4 million, or $0.17 per diluted share, EPS $0.17 per diluted share.
“Total revenue was $298.4 million, compared to $289.6 million for the third quarter of fiscal 2022. GAAP net income was $16.4 million, or $0.17 per diluted share, compared to GAAP net income of $39.6 million, or $0.39 per diluted share, for the third quarter of fiscal 2022.”
Dolby Laboratories, Inc. reported the fiscal quarter ended March 31, 2023 results: revenue $375.9 million, net income $95.7 million, EPS $0.98 per diluted share.
“Total revenue was $375.9 million, compared to $334.4 million for the second quarter of fiscal 2022. GAAP net income was $95.7 million, or $0.98 per diluted share, compared to GAAP net income of $36.7 million, or $0.36 per diluted share, for the second quarter of fiscal 2022.”
Dolby Laboratories, Inc. reported the first quarter of fiscal 2023 results: revenue $334.9 million, net income $79.4 million, EPS $0.82.
“Total revenue was $334.9 million, compared to $351.6 million for the first quarter of fiscal 2022. GAAP net income was $79.4 million, or $0.82 per diluted share, compared to GAAP net income of $80.0 million, or $0.77 per diluted share, for the first quarter of fiscal 2022.”
Dolby Laboratories, Inc. reported Full Year Fiscal 2022 results: revenue $1.25 billion, net income $184.1 million, EPS $1.81 per diluted share.
“Total revenue was $1.25 billion, compared to $1.28 billion for the full year of fiscal 2021. GAAP net income was $184.1 million, or $1.81 per diluted share, compared to GAAP net income of $310.2 million, or $2.97 per diluted share, for the full year of fiscal 2021.”
Dolby Laboratories, Inc. reported Fourth Quarter Fiscal 2022 results: revenue $278.2 million, net income $27.8 million, EPS $0.28 per diluted share.
“Total revenue was $278.2 million, compared to $285.0 million for the fourth quarter of fiscal 2021. GAAP net income was $27.8 million, or $0.28 per diluted share, compared to GAAP net income of $44.2 million, or $0.42 per diluted share, for the fourth quarter of fiscal 2021.”
Tony Prophet was appointed as Director at Dolby Laboratories, Inc..
“the Board of Directors (the “Board”) of the Company has appointed Tony Prophet to the Board, effective as of December 6, 2021”
Giles Baker changed role as Senior Vice President, Cloud Media Solutions at Dolby Laboratories, Inc..
“Also on November 9, 2021, the Company announced that Giles Baker will transition from his role as Senior Vice President, Consumer Entertainment Group, to Senior Vice President, Cloud Media Solutions, and will no longer serve as a Section 16 officer for purposes of federal securities laws.”
Lewis Chew retired as Executive Vice President and Chief Financial Officer at Dolby Laboratories, Inc..
“Mr. Chew ceased to serve as Chief Financial Officer effective as of the appointment of Mr. Park”
Robert J. Park was appointed as Senior Vice President and Chief Financial Officer at Dolby Laboratories, Inc..
“On October 15, 2021, Dolby Laboratories, Inc. (the “Company”) appointed Robert J. Park, age 51, as Senior Vice President and Chief Financial Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.